ARCH Venture Partners
VC · Chicago (United States)
Sign up free to access full profile and submit your pitch.
About
ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories. ARCH has raised ten venture funds totaling over $3 billion and has invested in the earliest venture capital rounds for more than 150 companies. ARCH investors include major corporations, pension funds, endowment funds, financial institutions, and private investors.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of ARCH Venture Partners
Other investors that have backed the same portfolio companies as ARCH Venture Partners. Expand any entry to see the shared portfolio companies.
- 32 shared
Shared portfolio companies
- Aera Therapeutics Inc.
- Aledade, Inc.
- Areteia Therapeutics, Inc.
- Aspen Neuroscience, Inc.
- Beam Therapeutics Inc.
- Bitterroot Bio, Inc.
- Boundless Bio, Inc.
- Carrick Therapeutics, Ltd.
- Chroma Medicine, Inc.
- Editas Medicine, Inc.
- Encoded Therapeutics, Inc.
- Encodia, Inc.
- Gate Bioscience, Inc.
- Insitro, Inc.
- LifeMine Therapeutics, Inc.
- Locanabio, Inc.
- Maze Therapeutics, Inc.
- Moonwalk Biosciences, Inc.
- National Resilience, Inc.
- nChroma Bio
- Parabilis Medicines, Inc.
- Paradigm Health, Inc.
- Pelage Pharmaceuticals, Inc.
- Prime Medicine, Inc.
- RhyGaze AG
- Rippl Care, Inc.
- ROME Therapeutics, Inc.
- Sana Biotechnology, Inc.
- Sonoma Biotherapeutics, Inc.
- Tome Biosciences, Inc.
- Treeline Biosciences, Inc.
- Vir Biotechnology, Inc.
- 22 shared
Shared portfolio companies
- AgBiome, Inc.
- Arivale Inc.
- Dewpoint Therapeutics, Inc.
- Editas Medicine, Inc.
- eGenesis, Inc.
- Faraday Pharmaceuticals, Inc.
- Fate Therapeutics, Inc.
- Gossamer Bio, Inc.
- Impinj, Inc.
- KSQ Therapeutics, Inc.
- MedVantx, Inc.
- Metacrine, Inc.
- Neumora Therapeutics, Inc.
- Paratus Sciences Corporation
- Pulmatrix, Inc.
- Scholar Rock Holding Corporation
- Scholar Rock, Inc.
- Soufflé Therapeutics, Inc.
- Sunbird Bio Pte. Ltd
- Syros Pharmaceuticals, Inc.
- Tome Biosciences, Inc.
- Volastra Therapeutics, Inc.
- 21 shared
Shared portfolio companies
- Autobahn Therapeutics, Inc.
- Boundless Bio, Inc.
- City Therapeutics, Inc.
- eGenesis, Inc.
- Erasca, Inc.
- Gossamer Bio, Inc.
- KSQ Therapeutics, Inc.
- Kura Oncology, Inc.
- LifeMine Therapeutics, Inc.
- Locanabio, Inc.
- Metacrine, Inc.
- Mirador Therapeutics, Inc.
- Neumora Therapeutics, Inc.
- Orbital Therapeutics, Inc.
- Parabilis Medicines, Inc.
- Pretzel Therapeutics, Inc.
- Scholar Rock Holding Corporation
- Scholar Rock, Inc.
- Seaport Therapeutics, Inc.
- SIRONAX
- Syros Pharmaceuticals, Inc.
- 16 shared
Shared portfolio companies
- Aera Therapeutics Inc.
- Beam Therapeutics Inc.
- Denali Therapeutics Inc.
- Hua Medicine (Shanghai) Ltd.
- LunaPBC, Inc.
- nChroma Bio
- Neumora Therapeutics, Inc.
- Paradigm Health, Inc.
- Prime Medicine, Inc.
- Quantum Circuits, Inc.
- RhyGaze AG
- Rippl Care, Inc.
- Sana Biotechnology, Inc.
- SIRONAX
- Tenvie Therapeutics, Inc.
- Xaira Therapeutics, Inc.
- 13 shared
Shared portfolio companies
- 12 shared
- 11 shared
Shared portfolio companies
- 11 shared
Shared portfolio companies
- 10 shared
Shared portfolio companies
- ApoGen Biotechnologies, Inc.
- Fate Therapeutics, Inc.
- Genetix Biotherapeutics, Inc.
- HealthTech Services Corporation
- Lyell Immunopharma, Inc.
- Magnolia Neurosciences Corporation
- Proniras Corporation
- Rapport Therapeutics, Inc.
- ROME Therapeutics, Inc.
- SonoThera, Inc.
.png)




